Clinical Trial Update: Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating etanercept in rheumatoid arthritis patients who lost response to adalimumab; study terminated with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Amgen | Conditions: Moderate to Severe Rheumatoid Arthritis | Phase 4 | Status: TERMINATED | Results posted: 2016-07-11